(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4...duals who suffer from irritable bowel syndrome (IB...ffects approximately 10-15% or more of the general...eeze too hard or not hard enough, causing food to ...oo slowly. The disease typically affects women, mo...
...als in the NHS have confirmed that around 1,200 jo...ue to the streamlining process following the merge...roposed cuts, which are subject to official consul... the next 18 months. The concerned unions fear the...
...ts receiving highly active anti-retroviral therapy... a break in the treatment, according to new resear...ations for HIV could be better off if they took br... could mean substantial cost savings for patients ...
...ing to a research conducted by the Department of H...high amount of caffeine intake resulted in dizzine...h department has issued strong warning to public a...e. Even coffee shops in their menu cards have ind...
Other Medicine News:Health News:Dealing with IBS 2Health News:Hundreds Of Jobs To Be Lost With The Merger Of Two Major Hospitals In UK 2(Date:10/7/2008)...dy Showed Larazotide Acetate Prevented Immunologic...ents with Celiac Disease, Additional Data Indicate..., ORLANDO, Fla., Oct. 7 /- Alba Ther...inical studies this week at the American,College o...eting. Data from,study CLIN 1001-004, the first Ph...
(Date:10/7/2008)...n a clinical study of adults, VYVANSE taken once-d...ithin one week, PHILADELPHIA, Oct. 7 /PRNewswire-... the global specialty biopharmaceutical company, t...mber issue of the Journal of,Clinical Psychiatry f...ention Deficit Hyperactivity Disorder (ADHD) sympt...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientifi...rstCall/ -- Ironwood,Pharmaceuticals, Inc. (former...NYSE: FRX ) today announced the presentation of r...,s safety and efficacy in 420 patients with,irrita...ysis of the data,indicates that once- daily oral d...
(Date:10/7/2008)...ERKELEY, Calif., Oct. 7 /- Aerovance ...y data from a Phase I trial of its Aerovant,inhala...h no evidence of,local irritancy following asthma ...s 10 mg dose will be the highest of three doses in...tudy, which is scheduled to begin early,next year....
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Bio advancements Expected to Drive Burn Care Market Growth Up 24700 Million 1937 1Bio advancements Expected to Drive Burn Care Market Growth Up 24700 Million 1937 2Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co Infected With HIV 911 1Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co Infected With HIV 911 2Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co Infected With HIV 911 3Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co Infected With HIV 911 4PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation 909 1PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation 909 2PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation 909 3Attitudes toward mammography differ across ethnicities cultures backgrounds 6892 1Attitudes toward mammography differ across ethnicities cultures backgrounds 6892 2...RE)--Jun 12, 2007 - Inspire,Pharmaceuticals, Inc. ... collaborators related to Inspire will present,inf...emy of,Allergology and Clinical Immunology (EAACI)...d at the 30th European Cystic Fibrosis,Society (EC...k,Turkey., The EAACI Congress includes two presen...
...INESS WIRE)--Jun 11, 2007 - Repros,Therapeutics In...s,from its six month study of Proellex in the trea...urope, enrolled 39,premenopausal women and has com...ree dose levels of Proellex(TM) as well as a,posit...), a GnRH,agonist also known as Lupron(R) or leupr...
Other Medicine Technology:Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6Rapid Test Kit
The InTray™ GC is a novel device for the growth and detection of both Neisseria gonorrhoeae and Neisseria meningitidis. This product provides a long shelf life and is easily transportable as a
OneStep Strip Style Gonorrhea Test is a rapid direct binding test for the visual detection of gonorrhea antigen, in the secretory specimen and urine from urogenital system, as an aid in the diagnosis
...ser thermal keratoplasty (LTK). This procedure wa...reduction of hyperopia from +0.75 to +2.50 diopter...diopters of astigmatism and refractive stability f...surgery, LTK is not performed in an operating suit...
Medicine Products: